Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Updated on: June 19,2024 7

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Updated on:June 19,2024 7

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom

Updated on: March 25,2024 9

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom

Updated on:March 25,2024 9

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024 14

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024 14

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on: April 01,2024 18

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on:April 01,2024 18

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on: May 09,2024 4

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on:May 09,2024 4

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on: April 01,2024 17

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on:April 01,2024 17

Young cancer survivors in Europe get increased post-cure help

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageAs medical advances in oncology enable more patients to beat tumors, greater attention is being paid t

Updated on: February 03,2024 14

Young cancer survivors in Europe get increased post-cure help

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageAs medical advances in oncology enable more patients to beat tumors, greater attention is being paid t

Updated on:February 03,2024 14

Immune response to HIV virus linked to cancer mutations

by Federica Giannelli,University of SaskatchewanMadison Adolph and Linda Chelico (left) uncovered how enzymes in the immune system may “go rogue” and cause cancer. Credit: David Stobbe"Our

Updated on: May 07,2024 16

Immune response to HIV virus linked to cancer mutations

by Federica Giannelli,University of SaskatchewanMadison Adolph and Linda Chelico (left) uncovered how enzymes in the immune system may “go rogue” and cause cancer. Credit: David Stobbe"Our

Updated on:May 07,2024 16

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024 15

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024 15

Researchers discover potential attack strategy for aggressive breast cancer

by University of North Carolina at Chapel Hill School of MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained g

Updated on: June 22,2024 5

Researchers discover potential attack strategy for aggressive breast cancer

by University of North Carolina at Chapel Hill School of MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained g

Updated on:June 22,2024 5

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center Deputy Director and Associate Dean for Research at the Colorado School of Public Health. Credit: University of Colorado Cancer Ce

Updated on: April 23,2024 16

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center Deputy Director and Associate Dean for Research at the Colorado School of Public Health. Credit: University of Colorado Cancer Ce

Updated on:April 23,2024 16

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on: January 22,2024 19

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on:January 22,2024 19